Sohini Chattopadhyay

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Stem Cell Transplantation

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Joseph Devasia, Anu Korula, Kulkarni Uday Prakash, Fouzia N Aboobacker, Kavitha M Lakshmi, Alok Srivastava, Vikram Mathews, Aby Abraham, Biju George
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival. Annals of hematology 103 (3) (2024)
Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Joseph Devasia, Anu Korula, Kulkarni Uday Prakash, Fouzia N Aboobacker, Kavitha M Lakshmi, Alok Srivastava, Vikram Mathews, Aby Abraham, Biju George
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival. Annals of hematology (2024)
Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Joseph Devasia, Anu Korula, Kulkarni Uday Prakash, Fouzia N Aboobacker, Kavitha M Lakshmi, Alok Srivastava, Vikram Mathews, Aby Abraham, Biju George
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival. Annals of hematology 103 (3) (2024)
Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Joseph Devasia, Anu Korula, Kulkarni Uday Prakash, Fouzia N Aboobacker, Kavitha M Lakshmi, Alok Srivastava, Vikram Mathews, Aby Abraham, Biju George
Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival. Annals of hematology 103 (3) (2024)